Results 191 to 200 of about 1,835,390 (328)
Dual targeting of AKT and mTOR using MK2206 and RAD001 reduces tumor burden in an intracardiac colon cancer circulating tumor cell xenotransplantation model. Analysis of AKT isoform‐specific knockdowns in CTC‐MCC‐41 reveals differentially regulated proteins and phospho‐proteins by liquid chromatography coupled mass spectrometry. Circulating tumor cells
Daniel J. Smit+19 more
wiley +1 more source
Opercular Perivascular Space Mimicking a Space-Occupying Brain Lesion: A Short Case Series. [PDF]
Tumelkans R, Eraslan C, Balodis A.
europepmc +1 more source
This article advocates integrating temporal dynamics into cancer research. Rather than relying on static snapshots, researchers should increasingly consider adopting dynamic methods—such as live imaging, temporal omics, and liquid biopsies—to track how tumors evolve over time.
Gautier Follain+3 more
wiley +1 more source
Ligula intestinalis in Labeobarbus fish species at Lake Tana, Ethiopia: prevalence, histopathological investigation, and associated risk factors. [PDF]
Destaw T+4 more
europepmc +1 more source
Form and decoration of arrows from the highlands of Papua New Guinea [PDF]
Thelma Bush
openalex +1 more source
Inhibitor of DNA binding‐1 is a key regulator of cancer cell vasculogenic mimicry
Elevated expression of transcriptional regulator inhibitor of DNA binding 1 (ID1) promoted cancer cell‐mediated vasculogenic mimicry (VM) through regulation of pro‐angiogenic and pro‐cancerous genes (e.g. VE‐cadherin (CDH5), TIE2, MMP9, DKK1). Higher ID1 expression also increased metastases to the lung and the liver.
Emma J. Thompson+11 more
wiley +1 more source
Is endoscopic radiofrequency ablation safe and effective for treating rare neuroendocrine tumors of the minor papilla? [PDF]
Wang R+6 more
europepmc +1 more source
Comment on ‘Geomagnetic depth sounding by induction arrow representation: A review’ by G. P. Gregori and L. J. Lanzerotti [PDF]
Detlef Wolf
openalex +1 more source
Alectinib resistance in ALK+ NSCLC depends on treatment sequence and EML4‐ALK variants. Variant 1 exhibited off‐target resistance after first‐line treatment, while variant 3 and later lines favored on‐target mutations. Early resistance involved off‐target alterations, like MET and NF2, while on‐target mutations emerged with prolonged therapy.
Jie Hu+11 more
wiley +1 more source